EnWave Reports 2025 Third Quarter Consolidated Interim Financial Results
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the third quarter ended June 30, 2025.
Alle Werte sind in Tausend und in CAD angegeben, sofern nicht anders angegeben.
- Reported revenue for Q3 2025 of $2,744, an increase of $122 relative to the comparable period in the prior year. During the period, there was the completed fabrication of a large-scale 120kW REV™ machine for Procescir of Mexico and the initial fabrication of two 60kW REV™ machines sold to Microdried, EnWave’s longest standing royalty partner.
- Reported royalty revenues for Q3 2025 of $431, an increase of $6 relative to the comparable period in the prior year. Royalties grew due to the increased number of royalty partners, and the expansion of both product sales, and REV™ machine capacity utilization for the quarter, offset by a decrease in royalties associated with the license termination and machinery buyback from an Illinois, U.S. based cannabis company during the period.
- Gross margin for the three months ending Q3 2025 was 19% compared to 44% for the three months ending Q3 2024. The decrease in margin was primarily a result of the production sales mix and a high-margin large scale machine resale in the comparative period.
- Reported an increase in Selling, General & Administrative (“SG&A”) costs, including Research & Development (“R&D”) of $40 for Q3 2025 relative to the comparable period in the prior year, with the increase primarily related to sales personnel, increased tradeshow attendance, and the timing of patent maintenance fees, offset by a decrease in legal fees.
- Reported Adjusted EBITDA(1) loss for Q3 2025 of $575, a decrease of $660 from the comparable period in the prior year.
Konsolidierte finanzielle Leistung:
($ '000s) | Three months ended June 30. | Nine months ended June 30. | ||||
2025 | 2024 | Veränderung in % | 2025 | 2024 | Veränderung in % | |
Umsatzerlöse | 2,744 | 2,622 | 5% | 7,610 | 4,547 | 67% |
Direkte Kosten | (2,209) | (1,471) | 50% | (5,526) | (3,330) | 66% |
Bruttomarge | 535 | 1,151 | (54%) | 2,084 | 1,217 | 71% |
Betriebliche Aufwendungen | ||||||
Allgemeines und Verwaltung | 532 | 665 | (20%) | 1,541 | 1,742 | (11%) |
Vertrieb und Marketing | 485 | 358 | 35% | 1,407 | 1,149 | 22% |
Forschung und Entwicklung | 388 | 342 | 13% | 1,124 | 1,127 | (0%) |
1,405 | 1,365 | 3% | 4,072 | 4,018 | 1% | |
Net loss – continuing operations | (1,162) | (235) | 394% | (2,462) | (2,938) | (16%) |
Net (loss) income – discontinued operations | (9) | (32) | (72%) | 1,109 | (35) | (3269%) |
Adjusted EBITDA(1) (loss) income | (575) | 85 | (776%) | (1,098) | (1,939) | (43%) |
(Loss) income per share: | ||||||
Continuing operations – basic and diluted | $ (0.01) | $ (0.01) | $ (0.02) | $ (0.02) | ||
Aufgegebene Geschäftsbereiche - unverwässert und verwässert | $ 0.00 | $ 0.00 | $ 0.01 | $ 0.00 | ||
Unverwässert und verwässert | $ (0.01) | $ (0.01) | $ (0.01) | $ (0.02) |
Note:
(1) Das bereinigte EBITDA ist eine Non-IFRS-Kennzahl. Eine Überleitung zum nächstgelegenen IFRS-Äquivalent finden Sie in der nachstehenden Offenlegung der Non-IFRS-Finanzkennzahlen.
Die konsolidierten Zwischenabschlüsse und die MD&A von EnWave sind auf SEDAR+ unter www.sedarplus.caund auf der Website des Unternehmens www.enwave.net verfügbar .
Key Financial Highlights for the Nine Months Ended June 30, 2025 (expressed in 000’s)
- Reported revenue of $7,610, an increase of $3,063 relative to the comparable period in the prior year. The increase was primarily related to improved machine sales.
- Reported Royalty revenues of $1,464, an increase of $145 or 11% relative to the comparative period in the prior year. Royalties grew due to the increased number of royalty partners, product sales, partner production, and exclusivity payments.
- Reported an increase in SG&A costs of $54 for the nine months ending June 30, 2025, relative to the comparable period in the prior year, with the increase primarily related to increased tradeshow attendance, recruitment costs, consulting fees and sales personnel, offset by reduced legal costs.
- Reported an Adjusted EBITDA(1) loss of $1,098 for the nine months ended June 30, 2025, an improvement of $841 from the comparable period in the prior year.
Significant Corporate Accomplishments in Q3 2025 and Subsequently:
- Signed an equipment purchase agreement and licence agreement amendment with MicroDried® for a 60kW REV™ machine and the exclusive rights to use REVTM technology for apple ingredient production in Washington, Oregon, and Idaho.
- Received the second progress payment related to the equipment purchase agreement with Procescir S.A. de C.V. of Mexico for a 120kW REV™ machine.
- Signed a license agreement amendment with Creations Foods US Inc. for an additional right to produce dried cheese snacks for pet treat applications on a non-exclusive basis in the United States.
- Signed a license agreement amendment with Procescir S.A. de C.V. for an additional right to produce fruit and vegetables products for well-known American snack brand.
- Signed an equipment purchase agreement with MicroDried® for two 10kWs and a 60kW REV™ machine and executed an additional royalty-bearing commercial license agreement for exclusive rights to produce mochi and Greek yogurt products in North America. The licence also includes the right to manufacture additional dairy applications, such as shredded cheese and cheesecake.
- Subsequent to the quarter, the Company signed an equipment purchase agreement with Dairy Concepts for two additional 10kW REV™ dehydration machines to expand dairy snack production in Europe.
- Subsequent to the quarter, the Company entered into an agreement with Clarus Securities Inc. (“Clarus”), as lead agent and sole bookrunner, pursuant to which Clarus agreed to sell, on a “best efforts” private placement basis, up to 7,500,000 common shares of the Company at a price per Share of C$0.40 for aggregate gross proceeds to the Company of up to C$3,000,000 (the “Offering”). The Offering closed on August 21, 2025, and was fully subscribed.
Nicht-IFRS-Finanzkennzahlen:
This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring income and expenses, restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.
Three months ended June 30. | Nine months ended June 30. | |||
($ '000s) | 2025 | 2024 | 2025 | 2024 |
Nettoverlust nach Ertragsteuern | (1,171) | (267) | (1,353) | (2,973) |
Amortisation und Abschreibung | 295 | 299 | 890 | 862 |
Aktienbasierte Vergütung | 59 | 32 | 330 | 218 |
Fremdwährungsverlust (-gewinn) | 194 | (9) | 53 | (36) |
Finanzielle Einnahmen | (26) | (42) | (103) | (148) |
Finanzaufwand | 65 | 40 | 205 | 103 |
Nicht wiederkehrender (Ertrag) Aufwand | - | - | (11) | - |
Aufgegebene Geschäftsbereiche | 9 | 32 | (1,109) | 35 |
Bereinigtes EBITDA | (575) | 85 | (1,098) | (1,939) |
Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca.
Über EnWave
EnWave ist weltweit führend in der Innovation und Anwendung der Vakuum-Mikrowellentrocknung. Von seinem Hauptsitz in Delta, BC, aus hat EnWave ein solides Portfolio an geistigem Eigentum entwickelt, seine Radiant Energy Vacuum (REV™)-Technologie perfektioniert und eine innovative Idee in eine bewährte, konsistente und skalierbare Trocknungslösung für die Lebensmittel-, Pharma- und Cannabisindustrie umgewandelt, die herkömmliche Trocknungsmethoden in Bezug auf Effizienz, Kapazität, Produktqualität und Kosten bei weitem übertrifft.
With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.
Die Strategie von EnWave besteht darin, lizenzpflichtige kommerzielle Lizenzen mit Lebensmittelherstellern zu unterzeichnen, die besser, schneller und wirtschaftlicher als mit Gefriertrocknung, Gestelltrocknung und Lufttrocknung trocknen wollen und von den folgenden Vorteilen profitieren: Herstellung aufregender neuer Produkte, bis zu siebenmal schnelleres Erreichen des optimalen Feuchtigkeitsgehalts und Verbesserung von Geschmack, Textur, Farbe und Nährwert der Produkte.
Erfahren Sie mehr unter EnWave.net.
EnWave Gesellschaft
Herr Brent Charleton, CFA
Präsident und Geschäftsführer
Für weitere Informationen:
Brent Charleton, CFA, Präsident und CEO unter +1 (778) 378-9616
E-Mail: bcharleton@enwave.net
Dylan Murray, CPA, CA, CFO unter +1 (778) 870-0729
E-Mail: dmurray@enwave.net
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information concerning the completion of the Offering, the use of proceeds of the Offering, the approval of the TSXV, the growth of the Company’s production capacity and the effects thereof, and the management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing or statements that include words such as “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend” and similar words are forward-looking statements. These statements are based on the current opinions and expectations of management and are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially as described in more detail in the Company’s recent securities filings available at www.sedarplus.ca, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not intend, and disclaims any obligation, except as required by applicable laws, to update or revise any forward-looking statements.
Weder die TSX Venture Exchange noch ihr Regulierungsdienstleister (gemäß der Definition dieses Begriffs in den Richtlinien der TSX Venture Exchange) übernehmen die Verantwortung für die Angemessenheit oder Richtigkeit dieser Pressemitteilung.